{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00833",
      "entity_text" : "adalimumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0923" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "In the United States, there are currently commercially available assays to measure serum drug levels of infliximab, adalimumab, certolizumab and golimumab, though the therapeutic cutoffs for certolizumab and golimumab are overall less certain [XREF_BIBR].",
  "reading_complete" : "2020-08-08T19:38:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:34:12Z",
  "trigger" : "levels",
  "evidence" : [ "levels of infliximab, adalimumab" ],
  "pmc_id" : "5547373",
  "score" : 0
}